Search Our Site

News tagged with:

"fda"

FDA approves brain implant to help reduce Parkinson’s disease and essential tremor symptoms

Originally posted on: FDA.gov The U.S. Food and Drug Administration today approved the Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson’s disease and essential tremor, a movement disorder that is one of the most common causes of tremors. The Brio Neurostimulation System can help some patients when... Read More »

Read More →

Originally posted on: FDA.gov The U.S. Food and Drug Administration today approved the Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson’s disease and essential tremor, a movement disorder that is one of the most common causes of tremors. The Brio Neurostimulation System can help some patients when… Read More »

[...]

Read More

Originally posted on FDA.gov The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy. Lung cancer is the leading cause of cancer death in the United States, with an estimated 224,210 new… Read More »

[...]

Read More

Page 4 of 4

Categories
Archives